Alberta Investment Management Corp Invests $6.05 Million in Humana Inc. (NYSE:HUM)

Alberta Investment Management Corp acquired a new position in shares of Humana Inc. (NYSE:HUM) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 23,840 shares of the insurance provider’s stock, valued at approximately $6,048,000.

A number of other institutional investors and hedge funds have also made changes to their positions in HUM. AMF Tjanstepension AB grew its position in shares of Humana by 166.8% during the third quarter. AMF Tjanstepension AB now owns 40,051 shares of the insurance provider’s stock worth $12,686,000 after buying an additional 25,041 shares in the last quarter. Stratos Wealth Advisors LLC boosted its holdings in Humana by 125.3% in the third quarter. Stratos Wealth Advisors LLC now owns 1,302 shares of the insurance provider’s stock valued at $412,000 after purchasing an additional 724 shares in the last quarter. Raymond James & Associates boosted its holdings in Humana by 3.5% in the third quarter. Raymond James & Associates now owns 99,530 shares of the insurance provider’s stock valued at $31,525,000 after purchasing an additional 3,341 shares in the last quarter. Copeland Capital Management LLC boosted its holdings in Humana by 27.4% in the third quarter. Copeland Capital Management LLC now owns 809 shares of the insurance provider’s stock valued at $256,000 after purchasing an additional 174 shares in the last quarter. Finally, Sequoia Financial Advisors LLC boosted its holdings in Humana by 3.2% in the third quarter. Sequoia Financial Advisors LLC now owns 2,408 shares of the insurance provider’s stock valued at $763,000 after purchasing an additional 74 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Trading Up 3.2 %

NYSE:HUM opened at $265.54 on Thursday. The stock has a fifty day moving average price of $269.80 and a two-hundred day moving average price of $291.28. The stock has a market capitalization of $31.97 billion, a price-to-earnings ratio of 26.69, a PEG ratio of 1.91 and a beta of 0.56. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46.

Humana (NYSE:HUM) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, sell-side analysts anticipate that Humana Inc. will post 16.49 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

HUM has been the subject of a number of research analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. TD Cowen upped their price target on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. JPMorgan Chase & Co. decreased their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday. Finally, Wells Fargo & Company decreased their price objective on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Nineteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Humana has a consensus rating of “Hold” and a consensus price target of $285.68.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.29% of the stock is currently owned by company insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.